Always Investigate Weight Discrepancies in Finished Goods Before Release

Investigate All Weight Discrepancies in Finished Goods Before GMP Release

Remember: GMP mandates that any discrepancy in the weight of finished goods must be promptly investigated and resolved prior to product release.

Why This Matters in GMP

Final weight reconciliation is one of the last and most critical quality control steps before releasing a batch for sale. Any unexplained variation—whether in number of units, net weight, or packaging count—could indicate mix-ups, dosage issues, missing product, or unaccounted loss. Releasing a batch with uninvestigated weight discrepancies not only violates GMP but also poses serious patient safety and regulatory risks. Discrepancies can stem from labeling errors, miscounts, line clearance lapses, or even product diversion.

Also Read: Never Blend Different Product Lots Without Prior QA Approval

Ignoring such deviations undermines batch integrity, documentation accuracy, and confidence in the manufacturing process. A robust reconciliation process backed by investigation protocols ensures that every unit in the market is correctly formulated, packaged, and labeled.

Regulatory and Compliance Implications

FDA 21 CFR Part 211.192 requires that any unexplained discrepancy be thoroughly investigated. EU GMP Chapter 6 reinforces the need for final product review, reconciliation, and QA decision-making. WHO GMP and Schedule M emphasize weight and quantity reconciliation as a release prerequisite. Inspectors assess batch

records, reconciliation sheets, deviation logs, and QA investigations. If a batch is released with known or unaddressed weight discrepancies, it can lead to product recalls, warning letters, or license suspension.

Also Read: Understanding the Role of Risk Management in GMP Compliance

Implementation Best Practices

Establish SOPs for final product reconciliation, including limits for acceptable variance and documentation formats.
Ensure that packaging operators and QA staff are trained to flag any mismatches between expected and observed weights or counts.
Initiate deviation reports for all discrepancies and route them through QA for root cause analysis and batch impact assessment.
Maintain secure records of each reconciliation, clearly marked with batch number, operator initials, and QA disposition.
Perform mock reconciliations during internal audits to verify compliance and detect potential process loopholes.

Regulatory References

FDA 21 CFR Part 211.192 – Discrepancy Investigation and Documentation
EU GMP Chapter 6 – Batch Release and Final Review
WHO GMP – Weight Reconciliation for Final Products
Schedule M – Packaging Integrity and Reconciliation Standards

Also Read: Never Permit Shift Handover Without Logging Critical GMP Updates